An independent source of information on U.S. brand name drugs for health professionals

Drugdocs Logo

An independent source of information on U.S. brand name drugs for health professionals

HomeDrugsGlossaryAboutContact Us

Menu

HomeDrugsGlossaryAboutContact Us

Drugs A-Z

ABCDE FGHIJKLMNOPQRSTUVWXYZ

DRUGS

A

B

C

D

E

F

G

H

I

J

K

L

M

N

O

P

Q

R

S

T

U

V

W

X

Y

Z

Krintafel

Chemical Nametafenoquine
Dosage FormTablet (oral; 150 mg)
Drug ClassAntimalarials
SystemBlood
CompanyGlaxoSmithKline plc
Approval Year2018

Indication

  • To treat Plasmodium vivax malaria in conjunction with appropriate therapy for acute Plasmodium vivax in patients ≥ 16 years of age in cases that are not acute.
Last updated on 10/14/2020

More on this drug: Clinical Trials

Have we missed a study, or would you like to comment on a study?

Document TitleYearSource
Krintafel (Tafenoquine) Prescribing Information 2018GlaxoSmithKline, Research Triangle Park, NC
Document TitleYearSource
Tafenoquine for primary and terminal prophylaxis of malaria in apparently healthy people: a systematic review. 2019Transactions of The Royal Society of Tropical Medicine and Hygiene